The gold standard biomarker in heart failure
As an initial test for diagnosis before echocardiography, Roche NT-proBNP is clinically validated to:
Roche NT-proBNP can aid patient discharge planning. Pre-discharge absolute value of, and relative changes in, Roche NT-proBNP during hospitalization can:
Roche NT-proBNP is a powerful prognosticator of patient outcomes, and is superior to BNP as a biomarker in patients treated with an angiotensin receptor-neprilysin inhibitor (ARNi).7,20-27
Monitoring NT-proBNP levels over time can provide insight into patients' disease progression.6,7,20,22,27
Watch video to learn more.
NT-proBNP: N-terminal prohormone of brain natriuretic peptide